COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Comparison of the CT OligoGen kit with cobas 4800 assay for detection of Chlamyd...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
Comparison of the CT OligoGen kit with cobas 4800 assay for detection of Chlamydia trachomatis
Comparación del kit CT OligoGen con el ensayo Cobas 4800 para la detección de Chlamydia trachomatis
Manuel Parra-Sáncheza,
Corresponding author
manuel.parra.exts@juntadeandalucia.es

Corresponding author.
, Ana Marcuello-Lópezb, Silvia García-Reya, Ismail Zakariya-Yousefa, Nieves Sivianes-Valdecantosa, Celestina Sierra-Atienzaa, Samuel Bernal-Martíneza, Isabel Pueyo-Rodrígezc, Estrella Martín-Mazuelosa, José Carlos Palomares-Folíaa
a Unit of Infectious Disease and Clinical Microbiology, Valme University Hospital, Seville, Spain
b Operon Inmuno & Molecular Diagnostics, Cuarte de Huerva, Zaragoza, Spain
c Center of Sexually Transmitted Infections of Seville, Seville, Spain
Read
14865
Times
was read the article
1259
Total PDF
13606
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2015.02.017
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 85 20 105
2024 March 263 16 279
2024 February 156 7 163
2024 January 232 7 239
2023 December 1153 8 1161
2023 November 522 27 549
2023 October 383 9 392
2023 September 268 12 280
2023 August 166 8 174
2023 July 42 9 51
2023 June 51 11 62
2023 May 130 17 147
2023 April 195 16 211
2023 March 1186 14 1200
2023 February 1248 9 1257
2023 January 1421 14 1435
2022 December 1580 15 1595
2022 November 442 24 466
2022 October 63 19 82
2022 September 97 17 114
2022 August 81 16 97
2022 July 60 16 76
2022 June 60 19 79
2022 May 77 17 94
2022 April 107 14 121
2022 March 167 23 190
2022 February 151 12 163
2022 January 99 11 110
2021 December 102 20 122
2021 November 106 21 127
2021 October 74 25 99
2021 September 44 25 69
2021 August 58 18 76
2021 July 67 17 84
2021 June 79 15 94
2021 May 90 6 96
2021 April 151 36 187
2021 March 73 9 82
2021 February 44 16 60
2021 January 55 11 66
2020 December 39 6 45
2020 November 56 12 68
2020 October 32 7 39
2020 September 64 34 98
2020 August 64 25 89
2020 July 44 4 48
2020 June 36 3 39
2020 May 39 16 55
2020 April 22 5 27
2020 March 39 8 47
2020 February 23 12 35
2020 January 46 7 53
2019 December 72 7 79
2019 November 32 10 42
2019 October 40 4 44
2019 September 53 15 68
2019 August 44 4 48
2019 July 38 13 51
2019 June 61 19 80
2019 May 137 47 184
2019 April 107 26 133
2019 March 21 3 24
2019 February 33 7 40
2019 January 14 7 21
2018 December 25 13 38
2018 November 29 4 33
2018 October 51 7 58
2018 September 36 7 43
2018 August 12 5 17
2018 July 19 1 20
2018 June 12 3 15
2018 May 16 2 18
2018 April 14 1 15
2018 March 15 2 17
2018 February 7 5 12
2018 January 16 3 19
2017 December 18 3 21
2017 November 14 5 19
2017 October 14 3 17
2017 September 12 2 14
2017 August 14 8 22
2017 July 21 3 24
2017 June 38 7 45
2017 May 18 8 26
2017 April 13 7 20
2017 March 29 7 36
2017 February 19 4 23
2017 January 24 2 26
2016 December 22 4 26
2016 November 36 4 40
2016 October 65 8 73
2016 September 58 7 65
2016 August 37 9 46
2016 July 40 4 44
2016 June 30 11 41
2016 May 20 1 21
2016 April 43 22 65
2016 March 45 26 71
2016 February 31 22 53
2016 January 58 42 100
2015 December 51 60 111
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos